Endocrine Effects of Marijuana
Todd T. Brown MD
Division of Endocrinology and Metabolism, Johns Hopkins University, Baltimore, Maryland.
Search for more papers by this authorCorresponding Author
Adrian S. Dobs MD, MHS
Division of Endocrinology and Metabolism, Johns Hopkins University, Baltimore, Maryland.
Division of Endocrinology and Metabolism, Johns Hopkins University, 1830 E. Monument St. Suite 333, Baltimore, MD 21287.Search for more papers by this authorTodd T. Brown MD
Division of Endocrinology and Metabolism, Johns Hopkins University, Baltimore, Maryland.
Search for more papers by this authorCorresponding Author
Adrian S. Dobs MD, MHS
Division of Endocrinology and Metabolism, Johns Hopkins University, Baltimore, Maryland.
Division of Endocrinology and Metabolism, Johns Hopkins University, 1830 E. Monument St. Suite 333, Baltimore, MD 21287.Search for more papers by this authorAbstract
In the 35 years since the active compound of marijuana Δ9-tetrahydrocannabinol, was isolated, the psychological and physiological impact of marijuana use has been actively investigated. Animal models have demonstrated that cannabinoid administration acutely alters multiple hormonal systems, including the suppression of the gonadal steroids, growth hormone, prolactin, and thyroid hormone and the activation of the hypothalamic-pituitary-adrenal axis. These effects are mediated by binding to the endogenous cannabinoid receptor in or near the hypothalamus. Despite these findings in animals, the effects in humans have been inconsistent, and discrepancies are likely due in part to the development of tolerance. The long-term consequences of marijuana use in humans on endocrine systems remain unclear.
REFERENCES
- 1 Harmon J, Aliapoulios MA: Gynecomastia in marijuana users. N Engl J Med 1972; 287: 936.
- 2 Murphy LL, Munoz RM, Adrian BA, Villanua MA: Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiology of Disease 1998; 5: 432–446.
- 3 Gerard CM, Mollereau C, Vassart G, Parmentier M: Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J 1991; 279: 129–134.
- 4 Galiegue S, Mary S, Marchand J, Dussossoy D, Carrieire D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P: Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995; 232: 54–61.
- 5 Purohit V, Ahluwahlia BS, Vigersky RA: Marihuana inhibits dihydrotestosterone binding to the androgen receptor. Endocrinology 1980; 107 (3): 848–850.
- 6 Sauer MA, Rifka SM, Hawks RL, Cutler GB, Loriaux DL: Marijuana: Interaction with the estrogen receptor. J Pharm Exp Ther 1983; 224 (2): 404–407.
- 7 Symons AM, Teale JD, Marks V: Effects of delta-9-tetrahydrocannabinol on the hypothalamic-pituitary-gonadal system in the maturing male rat. J Endocrinol 1976; 67: 43–44.
- 8 Murphy LL, Chandrashekar V, Bartke A: Delta-9-tetrohydrocannabinol inhibits pulsatile luteinizing hormone secretion in the male rat. Neuroendocrinol Lett 1994; 16: 1–7.
- 9 Smith CG, Moore CE, Besch NF, Besch PK: The effect of marijuana (Delta-9-THC) on the secretion of sex hormones in the mature male rhesus monkey. Clin Chem 1976; 22: 1184.
- 10 Collu R, Letarte J, Leboeuf G, Ducharme JR: Endocrine effects of chronic administration of psychoactive drugs to pre-pubertal male rats. Life Sci 1975; 16: 533–542.
- 11 Rosenkrantz H, Esber H: Cannabinoid-induced hormone changes in monkeys and rats. J Toxicol Envir Health 1980; 6 (2): 297–313.
- 12 Kolodny RC, Masters WH, Kolodner RM, Toro GI: Depression of plasma testosterone after chronic intensive marihuana use. N Engl J Med 1974; 290 (16): 872–874.
- 13 Kolodny RC, Lessin P, Toro G, Masters WH, Cohen J: Depression of testosterone with acute administration, in: MC Braude, S Szara (eds.), Pharmacology of Marijuana. New York: Raven, 1976; 217–225.
- 14 Mendelson J, Kuehnle J, Ellingboe J, Barbor T: Plasma testosterone levels before during and after chronic marijuana smoking. N Engl J Med 1974; 291 (20): 1051–1055.
- 15 Schaefer CF, Gunn CG, Dubowski KM: Normal plasma testosterone concentrations after marihuana smoking. N Engl J Med 1975; 292: 867–868.
- 16 Mendelson J, Ellingboe J, Kuehnle J, Mello NK: Effects of chronic marihuana use on integrated plasma testosterone and luteinizing hormone levels. J Pharmacol Exp Ther 1978; 207: 611–617.
- 17 Block RI, Farinpour R, Schlechte JA: Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle-stimulation hormone, prolactin and cortisol in men and women. Drug Alcohol Depend 1991; 28: 121–128.
- 18 de Fonseca F Rodriguez, Gorriti MA, Fernandez-Ruiz JJ, Palomo T, Ramos JA: Downregulation of rat brain cannabinoid binding sites after chronic Delta-9-THC treatment. Pharmacol Biochem Behav 1994; 47: 33–40.
- 19 Rubino T, Vigano D, Massi P, Parolaro D: Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55, 940. J Neurochem 2000; 75: 2080–2086.
- 20 Dixit VP, Sharma VN, Lohiya N: The effect of chronically administered cannabis on the testicular function in mice. Eur J Pharmacol 1974; 26: 111–114.
- 21 Dixit VP, Gupta CL, Agarwal M: Testicular degeneration and necrosis induced by chronic administration of cannabis extract in dogs. Endokrinologie 1977; 69: 299–305.
- 22 Thompson GR, Mason MM, Rosenkrantz H, Braude MC: Chronic oral toxicity of cannabinoids in rats. Toxicol Appl Pharmacol 1973; 25: 373–389.
- 23 Huang HFS, Nahas GG, Hembree WC: Effects of marihuana inhalation of spermatogenesis of the rat, in: GG Nahas, W Paton (eds.), Marihuana: Biological Effects. New York: Pergamon, 1979; 419–427.
- 24 Zimmerman AM, Zimmerman S, Raj A: Effects of cannabinoids on spermatogenesis in mice, in: GG Nahas, W Paton (eds.), Marihuana: Biological Effects. New York: Pergamon, 1979; 407.
- 25 Dalterio S, Bartke A, Burstein S: Cannabinoids inhibit testosterone secretion by mouse testes in vitro. Science 1977; 196: 1472–1473.
- 26 Legator MS, Weber E, Connor T, Stoeckel M: Failure to detect mutagenic effects of Delta-9-tetrahydrocannabinol in the dominant lethal test host-mediated assay, blood urine studies and cytogenetic evaluation in mice, in: MC Braude, S Szara (eds.), Pharmacology of Marijuana. New York: Raven, 1976; 699–709.
- 27 Dalterio S, Badr F, Bartke A, Mayfield D: Cannabinoids in male mice: Effects of fertility and spermatogenesis. Science 1982; 216: 315–316.
- 28 Murphy LL, Gher J, Steger RW, Bartke A: Effects of delta-9-tetrahydrocannabinol on copulatory behavior and neuroendocrine responses of male rats to female conspecifics. Pharmacol Biochem Behav 1994; 48 (4): 1011–1017.
- 29 Hembree WC, Zeidenberg P, Nahas GG: Marihuana's effect on human gonadal function, in: GG Nahas (ed.), Marihuana: Chemistry, Biochemistry, and Cellular Effects. New York: Springer-Verlag, 1976; 52.
- 30
Hembree WC,
Zeidenberg P,
Nahas GG: Changes in human spermatozoa associated with high dose marijuana smoking, in: GG Nahas,
W Paton (eds.), Marihuana: Biological Effects. New York: Pergamon, 1979; 429–439.
10.1016/B978-0-08-023759-6.50038-X Google Scholar
- 31
Issidorides MR: Observations in chronic hashish users: Nuclear aberrations in blood and sperm and abnormal acrosomes in spermatozoa, in: GG Nahas,
W Paton (eds.), Marihuana: Biological Effects. New York: Pergamon, 1979; 377–388.
10.1016/B978-0-08-023759-6.50033-0 Google Scholar
- 32 Sigman M, Howards SS: Male infertility, in: P Walsh (ed.), Campbell's Urology. 7th ed. Philadelphia: WB Saunders, 1998; 1287.
- 33 Glass AR: Gynecomastia, in: KL Becker (ed.), Principles and Practice of Endocrinology and Metabolism. Philadelphia: Lippincott, Williams, & Wilkins, 2001; 1200–1206.
- 34 Cates W, Pope JN: Gynecomastia and cannabis smoking: A nonassociation among U.S. Army soldiers. Am J Surg 1977; 134: 613–615.
- 35 Chakravarty I, Sheth AR, Ghosh JJ: Effect of acute THC treatment on serum luteinizing hormone and prolactin levels in the rat. Fertil Steril 1975; 26 (9): 947–948.
- 36 Dalterio SL, Mayfield DL, Bartke A: Effects of delta-9-THC on plasma hormone levels in female mice. Substance Alcohol Actions Misuse 1983; 4: 339–345.
- 37 Nir I, Ayalon D, Tsafriri A, et al: Suppression of cyclic surge of luteinizing hormone secretion and of ovulation in the rat by THC. Nature 1973; 243: 470–471.
- 38 Ayalon D, Nir I, Cordova T, Bauminger S, Puder M, et al: Acute effects of THC on the hypothalamo-pituitary ovarian axis in the rat. Neuroendocrinology 1977; 23: 31–42.
- 39 Dixit VP, Arya M, Lohiya NK: The effect of chronically administered cannabis extract on the female genital tract of mice and rats. Endokrinologie 1975; 66 (3): 365–368.
- 40 Asch RH, Fernandez EO, Smith CG, Pauerstein CJ: Precoital single doses of THC block ovulation in the rabbit. Fertil Steril 1979; 31: 331–334.
- 41 Besch NF, Smith CG, Besch PK, Kaufman RH: The effect of marihuana on the secretion of luteinizing hormone in ovariectomized rhesus monkey. Am J Obstet Gynec 1977; 128: 635–642.
- 42 Asch RH, Smith CG, Siler-Khodr TM, Pauerstein CJ: Effects of delta-9-THC during the follicular phase of the rhesus monkey. J Clin Endocrinol 1981; 52: 50–55.
- 43 Smith CG, Almirez RG, Berenberg J, Asch RH: Tolerance develops to the disruptive effects of THC on the primate menstrual cycle. Science 1983; 219: 1453–1455.
- 44
Sassenrath EN,
Chapman LF,
Goo GP: Reproduction in rhesus monkeys chronically exposed to moderate amounts of THC, in: GG Nahas,
W Paton (eds.), Marihuana: Biological Effects. New York: Pergamon, 1979; 501–512.
10.1016/B978-0-08-023759-6.50043-3 Google Scholar
- 45 Mendelson JH, Mello, NK, Ellingboe J, Skupny AST, Lex BW, Griffin M: Marihuana smoking suppresses luteinizing hormone in women. J Pharmacol Exp Ther 1986; 237: 862–866.
- 46 Mendelson JH, Mello NK: Effects of marijuana on neuroendocrine hormones in human males and females, in: MC Braude, JP Ludford (eds.), Marijuana Effects on the Endocrine and Reproductive Systems. Washington, DC: Government Printing Office, 1984; 97–109.
- 47 Mendelson JH, Cristofaro P, Ellingboe J, Benedikt R, Mello NK: Acute effects of marihuana on luteinizing hormone in menopausal women. Pharmacol Biochem Behav 1985; 23: 765–768.
- 48 Mendelson JH, Mello N: Marihuana effects on pituitary and gonadal hormones in women, in: GG Nahas (ed.), Marihuana and Medicine. Totawa, NJ: Humana Press, 1999; 385–392.
- 49 Bauman J: Marijuana and the female reproductive system: Testimony before the Subcommitteee on Criminal Justice of the Committee on the Judiciary, U.S. Senate Health, in: Consequences of Marijuana Use. Washington, DC: Government Printing Office, 1980; 85–86.
- 50 Mueller BA, Daling JR, Weiss NS, Moore DE: Recreational drug use and the risk of primary infertility. Epidemiology 1990; 1 (3): 195–200.
- 51 Fernandez-Ruiz JJ, Navarro M, Hernandez ML, Vaticon D, Ramos JA: Neuroendocrine effects of an acute dose of Delta-9-tetrahydrocannabinol: Changes in hypothalamic biogenic amines and anterior pituitary hormone secretion. Neuroendocrinol Lett 1992; 14: 349–355.
- 52 Bromley B, Zimmerman E: Divergent release of prolactin and corticosterone following Delta-9-THC injection in male rats. Fed Proc Fed Am Soc Exp Bio 1976; 35: 220.
- 53 Smith CG, Besch NF, Smith RG, Besch PK: Effect of THC on the hypothalamic-pituitary axis in the ovariectomized rhesus monkey. Fertil Steril 1979; 31: 335–339.
- 54 Bonnin A, Ramos JA, de Fonseca F Rodriquez, Cebeira M, Fernandez-Ruiz JJ: Acute effects of Delta-9-tetrahydrocannabinol on tuberoinfundibular dopaminergic activity, anterior pituitary sensitivity to dopamine and prolactin release vary as a function of estrous cycle. Neuroendocrinol 1993; 58: 280–286.
- 55 Fernandez-Ruiz JJ, Munoz RM, Romero J, Villanua MA, Makriyannis A, Ramos JA: Time course of effect of different cannabimimetics on prolactin and gonadotropin secretion: Evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics. Biochem Pharmacol 1997; 53: 1919–1927.
- 56 de Fonseca F Rodriguez, Wenger T, Navarro M, Murphy LL: Effects of Delta-9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: Evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells. Brain Res 1999; 841 (1–2): 114–122.
- 57 Dax EM, Pilotte NS, Adler WH, Nagel JE, Lange WR: The effects of 9-ene-tetrahydrocannabinol on hormone release and immune function. J Steroid Biochem 1989; 34: 263–270.
- 58 Mendelson JH, Mello NK, Ellingboe J: Acute effects of marihuana smoking on prolactin levels in human females. J Pharmacol Exp Ther 1985; 232 (1): 220–222.
- 59 Herkenham, M Lynn AB, Johnson MR, Melvin LS, deCosta BR, Rice KC: Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J Neurosci 1990; 11: 563–583.
- 60 Puder M, Weidenfeld J, Chowers I, Nir I, Conforti H, Siegel RA: Corticotropin and corticosterone secretion following Delta-1-tetrohydrocannabinol in intact and hypothalamic deafferented male rats. Exp Brain Res 1982; 46: 85–88.
- 61 Jackson AL, Murphy LL: Role of hypothalamic-pituitary-adrenal axis in the suppression of luteinizing hormone release by Delta-9-THC. Neuroendocrinology 1997; 65: 446–452.
- 62 de Fonseca F Rodriguez, Murphy LL, Bonnin A, Eldridge JC, Bartke A, Fernandez-Ruiz JJ: Delta-9-tetrahydrocannabinol administration affects anterior pituitary, corticoadrenal and adrenomedullary function in male rats. Neuroendocrinology (Life Sci Adv) 1992: 147–156.
- 63 Kubena RK, Perhach JC, Barry H 3rd: Coticosterone elevation mediated centrally by Delta-1-tetrahydrocannabinol in rats. Eur J Pharmacol 1971; 14: 89–94.
- 64 Martin-Calderon JL, Munoz RM, Villanua MA, Arco I, Moreno JL, de Fonseca F Rodriguez, Navarro M: Characterization of the acute endocrine actions of (−)-11-hydroxy-Delta-8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats. Euro J Pharmacol 1998; 344: 77–86.
- 65 Cone EJ, Johnson RE, Moore JD, Roache JD: Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects. Pharmac Biochem Behav 1986; 24: 1749–1754.
- 66 Benowitz NL, Jones RT, Lerner CB: Depression of growth hormone and cortisol response to insulin-induced hypoglycemia after prolonged oral Delta-9-tetrahydrocannabinol. J Clin Endocr Metab 1976; 42: 938–941.
- 67 Rettori V, Wenger T, Snyder G, Dalterio S, McCann SM: Hypothalamic action of Delta-9-tetrahydrocannabinol to inhibit the release of prolactin and growth hormone in the rat. Neuroendocrinology 1988; 47: 498–503.
- 68 Kokka N, Garcia JF: Effects of Delta-9-THC on growth hormone and ACTH in rats. Life Sci 1974; 15: 329–338.
- 69 Miras CJ: Some aspects of cannabis action, in: GEW Wolstenhome, J Knight (eds.), Hashish: Its Chemistry and Pharmacology. Boston: Little, Brown, 1965; 37–52.
- 70 Hillard CJ, Farber NE, Hagen T, Bloom AS: The effects of THC on serum thyrotropin levels in the rat. Pharmacol Biochem Behav 1984; 20: 547–550.
- 71 Nazar B, Kairys DJ, Fowler R, Harclerode J: Effects of Delta-9-tetrahydrocannabinol on serum thyroxine concentrations in the rat. J Pharm Pharmacol 1981; 21: 208–214.
- 72 Lomax P: The effect of marijuana on pituitary thyroid activity in the rat. Agents and Actions 1970; 1: 252–257.
- 73 Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miuras GI, Palmiter RD, Sugiura T, Kunos G: Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001; 410: 822–825.
- 74 Mattes RD, Engelman K, Shaw LM, Elsohly MA: Cannabinoids and appetite stimulation. Pharmacol Biochem Behav 1994; 49: 187–195.